| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Announcement
|
Pestell, Katharine
|
|
2003
|
24 |
11 |
p. 559-
1 p.
|
article
|
| 2 |
Anthrax mounts a nuclear attack on glucocorticoid signaling
|
Kliewer, Steven A
|
|
2003
|
24 |
11 |
p. 558-559
2 p.
|
article
|
| 3 |
cNOS–iNOS paradigm and arginase in asthma
|
Ricciardolo, Fabio L.M
|
|
2003
|
24 |
11 |
p. 560-561
2 p.
|
article
|
| 4 |
Contents page + Editorial Board
|
|
|
2003
|
24 |
11 |
p. i-
1 p.
|
article
|
| 5 |
Divergence and complexities in DAG signaling: looking beyond PKC
|
Yang, ChengFeng
|
|
2003
|
24 |
11 |
p. 602-608
7 p.
|
article
|
| 6 |
Leading the charge – pioneering treatments in the fight against neuropathic pain
|
Dickinson, Tracey
|
|
2003
|
24 |
11 |
p. 555-557
3 p.
|
article
|
| 7 |
Neuroadaptive effects of active versus passive drug administration in addiction research
|
Jacobs, Edwin H
|
|
2003
|
24 |
11 |
p. 566-573
8 p.
|
article
|
| 8 |
Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders
|
Holmes, Andrew
|
|
2003
|
24 |
11 |
p. 580-588
9 p.
|
article
|
| 9 |
RAMPs: 5 years on, where to now?
|
Morfis, Maria
|
|
2003
|
24 |
11 |
p. 596-601
6 p.
|
article
|
| 10 |
Response to Mousavizadeh et al.: Oxidative toxicity and glutamate excitotoxicity in multiple sclerosis
|
Neuhaus, Oliver
|
|
2003
|
24 |
11 |
p. 564-565
2 p.
|
article
|
| 11 |
Response to Ricciardolo: The functional significance of arginase in asthma is supported by gene expression
|
Meurs, Herman
|
|
2003
|
24 |
11 |
p. 562-563
2 p.
|
article
|
| 12 |
Targeting thrombin – rational drug design from natural mechanisms
|
Huntington, James A
|
|
2003
|
24 |
11 |
p. 589-595
7 p.
|
article
|
| 13 |
The annexin 1 receptor(s): is the plot unravelling?
|
Perretti, Mauro
|
|
2003
|
24 |
11 |
p. 574-579
6 p.
|
article
|
| 14 |
Uric acid: a novel treatment strategy for multiple sclerosis
|
Mousavizadeh, Kazem
|
|
2003
|
24 |
11 |
p. 563-564
2 p.
|
article
|
Journal description